On 7 November 2025, the Interreg ALCOVE research project, carried out through France–Belgium cooperation and coordinated by CHU de Lille, was highlighted in the #12:45 news programme of M6, as part of the Mois Sans Tabac campaign.
This report offered a powerful illustration of the project’s objectives, ambitions and ongoing developments, with contributions from researchers and healthcare professionals.
A warm congratulations to the consortium members who took part and shared their insights, including:
- Prof. Sébastien Hulo, Project Coordinator (CHU de Lille)
- Prof. Arnaud Scherpereel (CHU de Lille)
- Justin DM Martin (University of Liège – SAM Sensing of Atmospheres and Monitoring)
- Driss LAHEM (Materia Nova)
- Marc Debliquy (UMONS – Research, Innovation & Entrepreneurship)
Funded by Interreg France–Wallonie–Vlaanderen, ALCOVE aims to revolutionise lung cancer screening by analysing exhaled air from at-risk individuals using an innovative electronic nose.
This collaborative project — involving hospitals, laboratories and universities — is fully aligned with a societal impact approach, striving for earlier detection of lung cancer across the cross-border region.
This national coverage is a strong recognition of the collective efforts led by a multidisciplinary team committed to improving the health pathways of the most vulnerable populations.
A heartfelt thank‑you to the entire ALCOVE team — researchers, clinicians and engineers — for your dedication and commitment.
